Search

everythinglearnresearchcommunity

for

Search:↓

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Linagliptin may cause hair loss and skin blisters.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Apremilast shows promise for several skin conditions but needs more research.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.